I agree that this site is using cookies. You can find further informations here.
X
Mikami, Shigeru
171  results:
?
1

Comparison of six hepatocellular carcinoma prediction model..:

Toyoda, Hidenori ; Tada, Toshifumi ; Uojima, Haruki...
Journal of Gastroenterology and Hepatology.  39 (2024)  5 - p. 949-954 , 2024
Link: https://doi.org/10.1111/..
 
?
2

ALBI score predicts morphological changes in esophageal var..:

Atsukawa, Masanori ; Tsubota, Akihito ; Kondo, Chisa...
Journal of Gastroenterology.  59 (2024)  8 - p. 709-718 , 2024
Link: https://doi.org/10.1007/..
 
?
3

Kinetics of the hepatitis B core‐related antigen and treatm..:

Itokawa, Norio ; Atsukawa, Masanori ; Tsubota, Akihito...
Hepatology Research.  , 2024
Link: https://doi.org/10.1111/..
 
?
4

WED-283 The distribution of fibrosis-4 index and vibration-..:

Ogawa, Yuji ; Tomeno, Wataru ; Yasushi, Imamura...
Journal of Hepatology.  80 (2024)  - p. S541 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Mac‐2‐binding protein glycan isomer predicts all malignanci..:

Kawata, Kazuhito ; Atsukawa, Masanori ; Ohta, Kazuyoshi...
Hepatology Communications.  6 (2022)  8 - p. 1855-1869 , 2022
Link: https://doi.org/10.1002/..
 
?
6

International multicenter validation of GES score for HCC r..:

Shiha, Gamal ; Soliman, Reham ; Mikhail, Nabiel N. H....
Journal of Viral Hepatitis.  29 (2022)  9 - p. 807-816 , 2022
Link: https://doi.org/10.1111/..
 
?
7

The Impact of Cirrhosis and History of Hepatocellular Carci..:

Toyoda, Hidenori ; Atsukawa, Masanori ; Uojima, Haruki...
Gastro Hep Advances.  1 (2022)  4 - p. 508-515 , 2022
Link: https://doi.org/10.1016/..
 
?
8

Antifibrotic effect and long‐term outcome of SGLT2 inhibito..:

Arai, Taeang ; Atsukawa, Masanori ; Tsubota, Akihito...
Hepatology Communications.  6 (2022)  11 - p. 3073-3082 , 2022
Link: https://doi.org/10.1002/..
 
?
9

Shorter pruritus period and milder disease stage are associ..:

Kawano, Tadamichi ; Atsukawa, Masanori ; Tsubota, Akihito...
Scientific Reports.  12 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
10

Risk factors for portopulmonary hypertension in patients wi..:

Atsukawa, Masanori ; Tsubota, Akihito ; Kondo, Chisa...
Hepatology International.  17 (2022)  1 - p. 139-149 , 2022
Link: https://doi.org/10.1007/..
 
?
11

Misunderstanding of hepatitis C virus (HCV) infection statu..:

Toyoda, Hidenori ; Yasuda, Satoshi ; Moriya, Akio...
Journal of Infection and Chemotherapy.  28 (2022)  9 - p. 1231-1234 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Time‐course changes in liver functional reserve after succe..:

Atsukawa, Masanori ; Tsubota, Akihito ; Kondo, Chisa...
Hepatology Research.  52 (2021)  3 - p. 235-246 , 2021
Link: https://doi.org/10.1111/..
 
?
13

Characteristics and Prognosis of De Novo Hepatocellular Car..:

Toyoda, Hidenori ; Hiraoka, Atsushi ; Uojima, Haruki...
Hepatology Communications.  5 (2021)  7 - p. 1290-1299 , 2021
Link: https://doi.org/10.1002/..
 
?
14

Effect of sodium-glucose cotransporter 2 inhibitor in patie..:

Arai, Taeang ; Atsukawa, Masanori ; Tsubota, Akihito...
Therapeutic Advances in Endocrinology and Metabolism.  12 (2021)  - p. 204201882110002 , 2021
Link: https://doi.org/10.1177/..
 
?
15

Real-World Virological Efficacy and Safety of Ledipasvir an..:

Tada, Toshifumi ; Kumada, Takashi ; Okushin, Hiroaki...
Infectious Diseases and Therapy.  10 (2020)  1 - p. 269-280 , 2020
Link: https://doi.org/10.1007/..
 
1-15